Transcriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma
ConclusionWe identified a group of Metallothionein genes as biomarkers to predict recurrence. The metallothionein genes were all down ‐regulated in tumor samples, suggesting that low metallothionein expression may be a promoter of tumor growth. In addition, using de novo assembly identified some unique biomarkers, further confirmed the necessity of conducting a de novo assembly in human cancer study.
Source: Molecular Genetics & Genomic Medicine - Category: Genetics & Stem Cells Authors: Sufang Wang,
Michael Gribskov Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Study | Transplants | Urology & Nephrology